Maximum quantity allowed is 999
请选择数量
CAS RN: 95058-81-4 | 產品號碼: G0544
| 產品號碼 | G0544 |
純度/分析方法 
|
>98.0%(HPLC) |
| 分子式 / 分子量 | C__9H__1__1F__2N__3O__4 = 263.20 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件
|
Frozen (<0°C) |
| 應避免的情況 | Heat Sensitive |
| 包裝和容器
|
1G-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 95058-81-4 |
| 相關CAS RN
|
122111-03-9 |
| Reaxys-RN | 5382060 |
| PubChem Substance ID | 468591927 |
| Merck Index(14) | 4386 |
| MDL編號 | MFCD00869720 |
產品規格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| Melting point | 217.0 to 222.0 °C |
| Specific rotation [a]20/D | 70.0 to 78.0 deg(C=1,MeOH) |
性質
| 熔點 | 219 °C |
| 比旋光 [α]D | 74° (C=1,MeOH) |
| Maximum Wavelength | 268 nm (EtOH) |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H315 : Causes skin irritation. H319 : Causes serious eye irritation. H361 : Suspected of damaging fertility or the unborn child. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P405 : Store locked up. |
相關法規
| RTECS # | HA3835000 |
運輸資料
| HS編碼* | 2934.99-000 |
Application
Autophagy research / Mitophagy research
References
- Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction
Application
Gemcitabine: A Fluorinated Deoxycytidine Analog with Antitumor Activity
Gemcitabine and its hydrochloride [G0367] are fluorinated deoxycytidine analogs with antitumor activity against solid tumors. Once inside the cell, gemcitabine is rapidly phosphorylated by deoxycytidine kinase to form the active metabolites gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). dFdCDP inhibits ribonucleotide reductase, which is responsible for producing the deoxynucleotides required for DNA synthesis and repair. dFdCTP can be incorporated into DNA, leading to inhibition of DNA synthesis, producing cell death in S phase (the phase of DNA synthesis). On the other hand, a concomitant treatment with gemcitabine and cisplatin [D3371] is used for the treatment of several different types of cancer. Cisplatin acts by formation of platinum (Pt)-DNA adducts; gemcitabine acts by dFdCTP incorporation into DNA, subsequently leading to inhibition of exonuclease and DNA repair. (The product is for research purpose only.)
References
- Gemcitabine: metabolism, mechanisms of action, and self-potentiation (a review)
- Gemcitabine. A review of its pharmacology and clinical potential in non-small-cell lung cancer and pancreatic cancer
- Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine) (a review)
- Synergistic interaction between cisplatin and gemcitabine in vitro
- Validated assays for the determination of gemcitabine in human plasma and urine using high-performance liquid chromatography with ultraviolet detection
- Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry
文檔
產品介紹報導
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。